Source:http://linkedlifedata.com/resource/pubmed/id/12485460
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2002-12-17
|
pubmed:abstractText |
The female reproductive organs (ovary, uterus, and placenta) are some of the few adult tissues that exhibit regular intervals of rapid growth. They also are highly vascular and have high rates of blood flow. Angiogenesis, or vascular growth, is therefore an important component of the growth and function of these tissues. As with many other tissues, vascular endothelial growth factors (VEGFs) and fibroblast growth factors (FGFs) appear to be major angiogenic factors in the female reproductive organs. A variety of pathologies of the female reproductive organs are associated with disturbances of the angiogenic process, including dysfunctional uterine bleeding, endometrial hyperplasia and carcinoma, endometriosis, failed implantation and subnormal foetal growth, myometrial fibroids (uterine leiomyomas) and adenomyosis, ovarian hyperstimulation syndrome, ovarian carcinoma, and polycystic ovary syndrome. These pathologies are also associated with altered expression of VEGFs and/or FGFs. In the near future, angiogenic or antiangiogenic compounds may prove to be effective therapeutic agents for treating these pathologies. In addition, monitoring of angiogenesis or angiogenic factor expression may provide a means of assessing the efficacy of these therapies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides...,
http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0959-9673
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
151-63
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12485460-Endothelial Growth Factors,
pubmed-meshheading:12485460-Female,
pubmed-meshheading:12485460-Genital Diseases, Female,
pubmed-meshheading:12485460-Genitalia, Female,
pubmed-meshheading:12485460-Humans,
pubmed-meshheading:12485460-Intercellular Signaling Peptides and Proteins,
pubmed-meshheading:12485460-Lymphokines,
pubmed-meshheading:12485460-Neovascularization, Pathologic,
pubmed-meshheading:12485460-Neovascularization, Physiologic,
pubmed-meshheading:12485460-Placenta,
pubmed-meshheading:12485460-Vascular Endothelial Growth Factor A,
pubmed-meshheading:12485460-Vascular Endothelial Growth Factors
|
pubmed:year |
2002
|
pubmed:articleTitle |
Angiogenesis in the female reproductive organs: pathological implications.
|
pubmed:affiliation |
Department of Animal and Range Sciences, North Dakota State University, Fargo, ND 58105-5727, USA. Larry.Reynolds@ndsu.nodak.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Review,
Research Support, Non-U.S. Gov't
|